Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Join | Sign in
Home>Resources>Webcasts>This Webcast
  Webcasts
Protons, Heat and Mechanical Force Converge to Gate Two-Pore Potassium Channels at the Selectivity Filter
Dr Slav Bagriantsev, University of California, speaking at Ion Channel Targets 2011.
Date Posted: Friday, March 02, 2012
Access to this article and other content is for registered users.

Join the Technology Networks Community

  • Access to the latest scientific news, products and research through Technology Networks
  • Upload and share your posters on ePosters
  • View a library of 1,800+ scientific and medical posters
  • A library of 3,000+ scientific videos on LabTube


Sign In



Forgotten your details? Click Here
If you already have an account with Technology Networks, please use your existing login details. If you do not yet have an account please join here.

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Related Content

Blood Test Trumps Accuracy of Standard Screening in Detecting Down Syndrome in Early Pregnancy
A blood test undertaken between 10 to 14 weeks of pregnancy may be more effective in diagnosing Down syndrome and two other less common chromosomal abnormalities than standard non-invasive screening techniques.
Thursday, April 02, 2015
Developing a Noninvasive Test for Endometriosis
UCSF researchers identify patterns of genetic activity that could help in early detection of disorder.
Monday, November 24, 2014
Environmental Carcinogens Leave Distinctive Genetic Imprints in Tumors
Chemically induced tumors bear ‘smoking gun’ traces that sharply differentiate them from genetically engineered cancers.
Thursday, November 06, 2014
Human Cancer Prognosis Is Related to Newly Identified Immune Cell
A rare population of tumor-associated “good” cells slows cancer.
Monday, October 20, 2014
Chromosome Therapy to Correct a Severe Chromosome Defect
Induced pluripotent stem cell reprogramming offers potential to correct abnormal chromosomes.
Tuesday, January 14, 2014
Type 1 Diabetes Drug Proves Effective in Clinical Trial
Drug developed by UCSF researcher shows promise for blocking advance of disease in earliest stages.
Thursday, August 08, 2013
Supreme Court Rules That Human Genes Can’t Be Patented
Most agree that the ruling reduces barriers to genetic testing and enables scientists to further genetic research and share data aimed ultimately at preventing and curing disease.
Friday, June 14, 2013
UCSF Medical Center Publishes First Sustainability Report
Report documents a variety of initiatives underway for constructing green buildings, conserving energy and water, offering sustainable food and creating systems to divert waste.
Friday, April 12, 2013
HIV Testing Increased and Infection Reduced in Africa with Community Intervention
Free mobile HIV testing and counseling, same-day results and post-test support reduces HIV infections by 14 percent.
Thursday, March 07, 2013
Stem Cell Survival Strategy Is Key to Blood and Immune System Health
Stem cells of the aging bone marrow recycle their own molecules to survive and keep replenishing the blood and immune systems as the body ages.
Monday, February 18, 2013
Scientists Identify Key Biological Mechanism in Multiple Sclerosis
Imaging study finds potential new target to combat disease.
Tuesday, December 04, 2012
Researchers Identify Protein Key in Proliferation of Lymphoma Cells
Inhibiting PERK protein could reduce formation of cancerous tumors.
Thursday, November 29, 2012
Multiple Sclerosis ‘Immune Exchange’ Between Brain and Blood is Uncovered
UCSF finding of movement by disease-causing B cells gives hope for new treatments and diagnostics.
Thursday, November 22, 2012
UCSF Receives $2 Million to Advance UC-Wide Biobanking Initiative
Goal of the project is to develop an ethical, efficient and sustainable system for obtaining, processing and sharing biospecimens and data.
Thursday, November 15, 2012
Heart Failure Drug Shows Promise in Phase III Clinical Trial
Results were presented by John Teerlink at the American Heart Association’s Scientific Sessions 2012.
Monday, November 12, 2012
Scientific News
NIH-funded Study Points Way Forward for Retinal Disease Gene Therapy
Benefits for Leber congenital amaurosis peak after one to three years, then diminish.
Study Points to Possible Treatment for Lethal Pediatric Brain Cancer
NIH-funded preclinical study suggests epigenetic drugs may be used to treat leading cause of pediatric brain cancer death.
Mutations in Two Genes Linked to Familial Pulmonary Fibrosis and Telomere Shortening
PARN and RTEL1 genes strengthen the link between lung fibrosis and telomere dysfunction.
Diet Swap has Dramatic Effects on Colon Cancer Risk for Americans and Africans
New study confirms that a high fibre diet can substantially reduce risk.
Statement on NIH Funding of Research Using Gene-Editing Technologies in Human Embryos
Researchers modify the gene responsible for a potentially fatal blood disorder using CRISPR/Cas9 technology.
Scientists Identify Key Receptors Behind Development of AML
Blocking ITIM-receptor signaling in combination with conventional therapies may represent a novel strategy for AML treatment.
Alcoholic Hepatitis Treatments Fail to Keep Patients Alive
The study is published in the New England Journal of Medicine.
Researchers Get Under the Skin to Develop New Transplant Technique
Research reveals new possibilities for islet and stem cell transplantation to treat diabetes and other diseases.
X-ray Study May Aid in Designing Better Blood Pressure Drugs
New atomic-scale details could help create more effective medications with fewer side effects.
Scherer to Receive Banting Medal for Diabetes Research
Medal recognizes significant, long-term contributions to the understanding, treatment, or prevention of diabetes.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters